| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Autoimmunity/Diabetes Group, The John P. Robarts Research Institute and
Departments of Microbiology and Immunology, and Medicine, University of Western Ontario, London, Ontario, Canada;
Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada;
Autoimmunity and Transplantation Division, The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital PO, Parkville, Victoria, Australia; and
¶ Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO 80262
The expression of pro(insulin) in the thymus may lead to the negative selection of pro(insulin) autoreactive T cells and peripheral tolerance to this autoantigen in type 1 diabetes (T1D). We investigated whether proinsulin is expressed in the thymus of young nonobese diabetic (NOD) mice, whether T cells from naive NOD female mice at weaning are reactive to mouse proinsulin, and the role of proinsulin as a pathogenic autoantigen in T1D. Proinsulin II mRNA transcripts were detected in the thymus of 2-wk-old NOD mice at similar levels to other control strains. Despite this expression, proinsulin autoreactive T cells were detected in the periphery of 2- to 3-wk-old naive NOD mice. Peripheral T cells reactive to the insulin, glutamic acid decarboxylase 65 (GAD65), GAD67, and islet cell Ag p69 autoantigens were also detected in these mice, indicating that NOD mice are not tolerant to any of these islet autoantigens at this young age. T cell reactivities to proinsulin and islet cell Ag p69 exceeded those to GAD67, and T cell reactivity to proinsulin in the spleen and pancreatic lymph nodes was directed mainly against a p24–33 epitope that spans the B chain/C peptide junction. Intraperitoneal immunization with proinsulin perinatally beginning at 18 days of age delayed the onset and reduced the incidence of T1D. However, s.c. immunization with proinsulin initiated at 5 wk of age accelerated diabetes in female NOD mice. Our findings support the notion that proinsulin p24–33 may be a primary autoantigen epitope in the pathogenesis of T1D in NOD mice.
This article has been cited by other articles:
|
|
 |
|
  M. G. Levisetti, D. M. Lewis, A. Suri, and E. R. Unanue Weak Proinsulin Peptide-Major Histocompatibility Complexes Are Targeted in Autoimmune Diabetes in Mice Diabetes, July 1, 2008; 57(7): 1852 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kobayashi, N. Abiru, T. Arakawa, K. Fukushima, H. Zhou, E. Kawasaki, H. Yamasaki, E. Liu, D. Miao, F. S. Wong, et al. Altered B:9 23 Insulin, When Administered Intranasally with Cholera Toxin Adjuvant, Suppresses the Expression of Insulin Autoantibodies and Prevents Diabetes J. Immunol., August 15, 2007; 179(4): 2082 - 2088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Narendran, A. M. Neale, B. H. Lee, K. Ngui, R. J. Steptoe, G. Morahan, O. Madsen, J. A. Dromey, K. P. Jensen, and L. C. Harrison Proinsulin is encoded by an RNA splice variant in human blood myeloid cells PNAS, October 31, 2006; 103(44): 16430 - 16435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Faideau, C. Lotton, B. Lucas, I. Tardivel, J. F. Elliott, C. Boitard, and J.-C. Carel Tolerance to Proinsulin-2 Is Due to Radioresistant Thymic Cells J. Immunol., July 1, 2006; 177(1): 53 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Garcia, K. R. Prabakar, J. Diez, Z. A. Cao, G. Allende, M. Zeller, R. Dogra, A. Mendez, E. Rosenkranz, U. Dahl, et al. Dendritic Cells in Human Thymus and Periphery Display a Proinsulin Epitope in a Transcription-Dependent, Capture-Independent Fashion J. Immunol., August 15, 2005; 175(4): 2111 - 2122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Toma, S. Haddouk, J.-P. Briand, L. Camoin, H. Gahery, F. Connan, D. Dubois-Laforgue, S. Caillat-Zucman, J.-G. Guillet, J.-C. Carel, et al. Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients PNAS, July 26, 2005; 102(30): 10581 - 10586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ejrnaes, N. Videbaek, U. Christen, A. Cooke, B. K. Michelsen, and M. von Herrath Different Diabetogenic Potential of Autoaggressive CD8+ Clones Associated with IFN-{gamma}-Inducible Protein 10 (CXC Chemokine Ligand 10) Production but Not Cytokine Expression, Cytolytic Activity, or Homing Characteristics J. Immunol., March 1, 2005; 174(5): 2746 - 2755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Chen, K. V. Salojin, Q.-S. Mi, M. Grattan, T. C. Meagher, P. Zucker, and T. L. Delovitch Insulin-Like Growth Factor (IGF)-I/IGF-Binding Protein-3 Complex: Therapeutic Efficacy and Mechanism of Protection against Type 1 Diabetes Endocrinology, February 1, 2004; 145(2): 627 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Faideau, J.-P. Briand, C. Lotton, I. Tardivel, P. Halbout, J. Jami, J. F. Elliott, P. Krief, S. Muller, C. Boitard, et al. Expression of Preproinsulin-2 Gene Shapes the Immune Response to Preproinsulin in Normal Mice J. Immunol., January 1, 2004; 172(1): 25 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dubois-Lafforgue, L. Mogenet, K. Thebault, J. Jami, P. Krief, and C. Boitard Proinsulin 2 Knockout NOD Mice: A Model for Genetic Variation of Insulin Gene Expression in Type 1 Diabetes Diabetes, December 1, 2002; 51(90003): S489 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Halbout, J.-P. Briand, C. Becourt, S. Muller, and C. Boitard T Cell Response to Preproinsulin I and II in the Nonobese Diabetic Mouse J. Immunol., September 1, 2002; 169(5): 2436 - 2443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Chentoufi and C. Polychronakos Insulin Expression Levels in the Thymus Modulate Insulin-Specific Autoreactive T-Cell Tolerance: The Mechanism by Which the IDDM2 Locus May Predispose to Diabetes Diabetes, May 1, 2002; 51(5): 1383 - 1390. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
